Van Gelder IC, Rienstra M, Bunting KV, et al
For patients without the aforementioned comorbidities with the primary goal of glycemic and weight management, GLP-1 and GIP/GLP-1 receptor agonists are recommended.(1) GLP-1 receptor agonists are not only efficacious for glucose lowering and achieving diabetes treatment goals, but have also demonstrated several added benefits in recent studies
P 24), ALC levels were significantly negatively correlated with severity scores: the higher the severity, the lower the ALC concentrations (r = 0.325, P = 0.007) (Figure 2)
doi: 10.1007/BF00492251 2 JorsalTRheeNAPedersenJWahlgrenCDMortensenBJepsenSLet al
This study suggests that the topical application of L-carnitine, combined with other lipolytic agents, may amplify the effects of a low-calorie diet and moderate physical activity on reducing localized fat deposits